AstraZeneca drops sharply as FTSE edges up
December 17, 2010 at 04:39 AM EST
The U.K.’s benchmark index edges slightly higher, while AstraZeneca shares come under pressure after a delay for the drug firm’s Brilinta heart drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.